ArticleFrontiers in pharmacology2026

Physiologically based pharmacokinetic model of two ALK inhibitors to inform drug and dosing regimens for brain metastasis patients.

Na Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.